Group structure
7 companies in 5 countries
Loading…
7 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 37
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BOVICAM 2020 mg / ml · Solution | Meloxicam | Canada | Marketed | 2023 |
| CEPESEDAN10 mg / ml · Solution | Detomidine | Canada | Marketed | 2010 |
| CEPETOR1 mg / ml · Solution | Medetomidine | Canada | Marketed | 2010 |
| CLOPROSTENOL VEYX0.25 mg / ml · Solution | Cloprostenol | Canada | Marketed | 2014 |
| CLOPROSTENOL VEYX SW175 mcg / 2 ml · Solution | Cloprostenol | Canada | Marketed | 2017 |
| DEXVETIDINE0.5 mg / ml · Solution | Dexmedetomidine | Canada | Marketed | 2019 |
| EMEQUEL10 mg / ml · Solution | Maropitant | Canada | Authorised | |
| ENROTRON 5050 mg / ml · Solution | Enrofloxacin | Canada | Marketed | 2021 |
| EPRINOVET5 mg / ml · Solution | Eprinomectin | Canada | Authorised | |
| FLUTREXIN50 mg / ml · Solution | Flunixin | Canada | Marketed | 2026 |
| GONAVET54 mcg / ml · Solution | Gonadorelin | Canada | Marketed | 2023 |
| HYMATIL300 mg / ml · Solution | Tilmicosin | Canada | Marketed | 2015 |
| KETOPROFEN V100 mg / ml · Solution | Ketoprofen | Canada | Marketed | 2016 |
| MAPRELIN XP-1075 mcg / ml · Solution | Peforelin | Canada | Marketed | 2020 |
| MOXICLOPRID 1040 mg / 0.4 ml + 10 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| MOXICLOPRID 100400 mg / 4 ml + 100 mg / 4 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| MOXICLOPRID 1880 mg / 0.8 ml + 8 mg / 0.8 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| MOXICLOPRID 20100 mg / 0.4 ml + 25 mg / 1 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| MOXICLOPRID 55250 mg / 2.5 ml + 62.5 mg / 2.5 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| MOXICLOPRID 940 mg / 0.4 ml + 4 mg / 0.4 ml · Solution | Imidacloprid, Moxidectin | Canada | Not marketed | 2023 |
| ORTHOXICAM5 mg / ml · Solution | Meloxicam | Canada | Authorised | |
| RESPIPULMIN0.025 mg / ml · Syrup | Clenbuterol | Canada | Marketed | 2012 |
| RESPIRAM20 mg / ml · Solution | Doxapram | Canada | Not marketed | 2010 |
| RESPOTIL250 mg / ml · Solution | Tilmicosin | Canada | Marketed | 2021 |
| REVERTOR5 mg / ml · Solution | Atipamezole | Canada | Marketed | 2010 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 37 | 36 | 1 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence: Norwegian Licence for Open Government Data
Report an error or request removalCorrections from the company itself are welcome.
Keep Modern’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.